Omnia Kutkat

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Drug Administration

Microbial Community

Respiratory Syndrome Coronavirus

Top Venues

Emerging microbes & infections

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Omnia Kutkat, Mokhtar R Gomaa, Yassmin Moatasim, Ahmed El Taweel, Mina Nabil Kamel, Mohamed El Sayes, Mohamed GabAllah, Ahmed M Kandeil, Pamela P McKenzie, Richard John Webby, Ghazi Kayali, Mohamed Ahmed Ali, Rabeh El Shesheny
Highly pathogenic avian influenza virus H5N1 clade 2.3.4.4b in wild rats in Egypt during 2023. Emerging microbes & infections 13 (1) (2024)
Mokhtar R Gomaa, Amira Sayed El Refay, Mahmoud M Shehata, Ahmed M Kandeil, Mina Nabil Kamel, Mohamed A Marouf, Mohamed GabAllah, Ahmed El Taweel, Ahmed E Kayed, Omnia Kutkat, Yassmin Moatasim, Sara H Mahmoud, Noura M Abo Shama, Mohamed El Sayes, Ahmed Mostafa, Rabeh El Shesheny, Pamela P McKenzie, Richard John Webby, Ghazi Kayali, Mohamed A Ali
Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort. PLoS pathogens 17 (3) (2021)
Ahmed Mostafa, Ahmed M Kandeil, Yaseen A M M Elshaier, Omnia Kutkat, Yassmin Moatasim, Adel Ahmed Rashad Ahmed, Mahmoud M Shehata, Mokhtar R Gomaa, Noura Mahrous, Sara H Mahmoud, Mohamed GabAllah, Hisham A Abbas, Ahmed El Taweel, Ahmed E Kayed, Mina Nabil Kamel, Mohamed El Sayes, Dina B Mahmoud, Rabeh El Shesheny, Ghazi Kayali, Mohamed Ahmed Ali
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. Pharmaceuticals (Basel, Switzerland) 13 (12) (2020)